To report an adverse event, we recommend contacting our Pharmacovigilance team using the email address provided above. If additional information is required, our team will get in touch with you.
Aligentis is committed to maintaining the highest standards of patient safety. All adverse event reports are reviewed in accordance with applicable pharmacovigilance regulations to help monitor the safety and benefit-risk profile of our products.